{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:34:29Z","timestamp":1787315669151,"version":"build-2736575974"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-SRF2022A-006"],"award-info":[{"award-number":["ARUK-SRF2022A-006"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although \u03b1-synuclein pathology is typically associated with Lewy body diseases and multiple systems atrophy, increasing evidence indicates that it also occurs in a group of lysosomal storage disorders termed sphingolipidoses caused by the incomplete degradation, and subsequent accumulation, of a class of lipids termed sphingolipids. Notably, a number of genes that cause sphingolipidoses are also risk genes for Lewy body diseases, suggesting aetiological links between these distinct disorders. In the present review, we discuss the sphingolipidoses in which \u03b1-synuclein pathology has been reported: Gaucher disease, Krabbe disease, metachromatic leukodystrophy, Tay-Sachs disease and Anderson-Fabry disease, and describe the characteristic clinical and pathological features of these disorders, in addition to the evidence suggesting \u03b1-synuclein pathology occurs in these disorders. Finally, we evaluate the pathological mechanisms that underlie these rare disorders, with particular attention to how the enzymatic deficiency, substrate accumulation, or both, could contribute to the genesis of \u03b1-synuclein pathology and the implications of this for Lewy body diseases.<\/jats:p>","DOI":"10.1007\/s00702-025-02925-z","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:53:52Z","timestamp":1744876432000},"page":"809-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sphingolipidoses: expanding the spectrum of \u03b1-synucleinopathies"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1752-5343","authenticated-orcid":false,"given":"Daniel","family":"Erskine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-3224","authenticated-orcid":false,"given":"Agnieszka K.","family":"Bronowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-1727","authenticated-orcid":false,"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-1700","authenticated-orcid":false,"given":"Johannes","family":"Attems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2925_CR1","doi-asserted-by":"publisher","first-page":"12462","DOI":"10.1038\/s41598-018-30808-9","volume":"8","author":"H Abdelkarim","year":"2018","unstructured":"Abdelkarim H, Marshall MS, Scesa G, Smith RA, Rue E, Marshall J, Elackattu V, Stoskute M, Issa Y, Santos M (2018) \u03b1-Synuclein interacts directly but reversibly with psychosine: implications for \u03b1-synucleinopathies. Sci Rep 8:12462","journal-title":"Sci Rep"},{"key":"2925_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12944-021-01466-0","volume":"20","author":"M Abed Rabbo","year":"2021","unstructured":"Abed Rabbo M, Khodour Y, Kaguni LS, Stiban J (2021) Sphingolipid lysosomal storage diseases: from bench to bedside. Lipids Health Dis 20:44","journal-title":"Lipids Health Dis"},{"key":"2925_CR3","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1038\/emm.2014.128","volume":"47","author":"E-J Bae","year":"2015","unstructured":"Bae E-J, Yang NY, Lee C, Lee H-J, Kim S, Sardi SP, Lee S-J (2015) Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and \u03b1-synuclein aggregation. Exp Mol Med 47:e153\u2013e153","journal-title":"Exp Mol Med"},{"key":"2925_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chemphyslip.2018.08.003","volume":"216","author":"E Bieberich","year":"2018","unstructured":"Bieberich E (2018) Sphingolipids and lipid rafts: novel concepts and methods of analysis. Chem Phys Lipids 216:114\u2013131","journal-title":"Chem Phys Lipids"},{"key":"2925_CR5","doi-asserted-by":"publisher","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","volume":"128","author":"AE Bley","year":"2011","unstructured":"Bley AE, Giannikopoulos OA, Hayden D, Kubilus K, Tifft CJ, Eichler FS (2011) Natural history of infantile GM2 gangliosidosis. Pediatrics 128:e1233\u2013e1241","journal-title":"Pediatrics"},{"key":"2925_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-10-28","volume":"10","author":"M Blomqvist","year":"2011","unstructured":"Blomqvist M, Gieselmann V, M\u00e5nsson J-E (2011) Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice. Lipids Health Dis 10:1\u20135","journal-title":"Lipids Health Dis"},{"key":"2925_CR7","doi-asserted-by":"crossref","unstructured":"Braun F, Abed A, Sellung D, Rogg M, Woidy M, Eikrem O, Wanner N, Gambardella J, Laufer SD, Haas F (2023) Accumulation of \u03b1-synuclein mediates podocyte injury in Fabry nephropathy. J Clin Investig, 133","DOI":"10.1172\/JCI157782"},{"key":"2925_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01004-6","volume":"8","author":"OR Brekk","year":"2020","unstructured":"Brekk OR, Korecka JA, Crapart CC, Huebecker M, Macbain ZK, Rosenthal SA, Sena-Esteves M, Priestman DA, Platt FM, Isacson O (2020) Upregulating \u03b2-hexosaminidase activity in rodents prevents \u03b1-synuclein lipid associations and protects dopaminergic neurons from \u03b1-synuclein-mediated neurotoxicity. Acta Neuropathol Commun 8:1\u201314","journal-title":"Acta Neuropathol Commun"},{"key":"2925_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10545-017-0098-3","volume":"41","author":"AB Burlina","year":"2018","unstructured":"Burlina AB, Polo G, Salviati L, Duro G, Zizzo C, Dardis A, Bembi B, Cazzorla C, Rubert L, Zordan R (2018) Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy. J Inherit Metabolic Disease: Official J Soc Study Inborn Errors Metabolism 41:209\u2013219","journal-title":"J Inherit Metabolic Disease: Official J Soc Study Inborn Errors Metabolism"},{"key":"2925_CR10","doi-asserted-by":"publisher","first-page":"e26159","DOI":"10.1371\/journal.pone.0026159","volume":"6","author":"B Byers","year":"2011","unstructured":"Byers B, Cord B, Nguyen HN, Sch\u00fcle B, Fenno L, Lee PC, Deisseroth K, Langston JW, Pera RR, Palmer TD (2011) Snca triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate \u03b1-synuclein and are susceptible to oxidative stress. PLoS ONE 6:e26159","journal-title":"PLoS ONE"},{"key":"2925_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1566523218666180404162622","volume":"18","author":"MB Cachon-Gonzalez","year":"2018","unstructured":"Cachon-Gonzalez MB, Zaccariotto E, Cox TM (2018) Genetics and therapies for GM2 gangliosidosis. Curr Gene Ther 18:68\u201389","journal-title":"Curr Gene Ther"},{"key":"2925_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/hmg\/ddt459","volume":"23","author":"M-B Cach\u00f3n-Gonz\u00e1lez","year":"2014","unstructured":"Cach\u00f3n-Gonz\u00e1lez M-B, Wang SZ, Ziegler R, Cheng SH, Cox TM (2014) Reversibility of neuropathology in Tay\u2013Sachs-related diseases. Hum Mol Genet 23:730\u2013748","journal-title":"Hum Mol Genet"},{"key":"2925_CR13","doi-asserted-by":"crossref","unstructured":"Campelo C, Silva RH (2017) Genetic Variants in SNCA and the Risk of Sporadic Parkinson\u2019s Disease and Clinical Outcomes: A Review. Parkinsons Dis, 2017, 4318416","DOI":"10.1155\/2017\/4318416"},{"key":"2925_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13023-024-03044-w","volume":"19","author":"S-C Chang","year":"2024","unstructured":"Chang S-C, Bergamasco A, Bonnin M, Bison\u00f3 TA, Moride Y (2024) A systematic review on the birth prevalence of metachromatic leukodystrophy. Orphanet J Rare Dis 19:80","journal-title":"Orphanet J Rare Dis"},{"key":"2925_CR15","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","volume":"160","author":"J Charrow","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ (2000) The gaucher registry: demographics and disease characteristics of 1698 patients with gaucher disease. Arch Intern Med 160:2835\u20132843","journal-title":"Arch Intern Med"},{"key":"2925_CR16","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2353\/ajpath.2008.070576","volume":"172","author":"C Chimenti","year":"2008","unstructured":"Chimenti C, Hamdani N, Boontje NM, Decobelli F, Esposito A, Bronzwaer JG, Stienen GJ, Russo MA, Paulus WJ, Frustaci A (2008) Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. Am J Pathol 172:1482\u20131490","journal-title":"Am J Pathol"},{"key":"2925_CR17","doi-asserted-by":"publisher","first-page":"1163184","DOI":"10.3389\/fnagi.2023.1163184","volume":"15","author":"LJ Chwiszczuk","year":"2023","unstructured":"Chwiszczuk LJ, Breitve MH, Kirsebom B-EB, Selnes P, Fl\u00f8vig JC, Knapskog A-B, Skogseth RE, Hubbers J, Holst-Larsen E, Rongve A (2023) The ANeED study\u2013ambroxol in new and early dementia with lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial. Front Aging Neurosci 15:1163184","journal-title":"Front Aging Neurosci"},{"key":"2925_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/acn3.193","volume":"2","author":"CI Dali","year":"2015","unstructured":"Dali CI, Barton NW, Farah MH, Moldovan M, Mansson JE, Nair N, Duno M, Risom L, Cao H, Pan L, Sellos-Moura M, Corse AM, Krarup C (2015) Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy. Ann Clin Transl Neurol 2:518\u2013533","journal-title":"Ann Clin Transl Neurol"},{"key":"2925_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ana.410310410","volume":"31","author":"GA De Veber","year":"1992","unstructured":"De Veber GA, Schwarting GA, Kolodny EH, Kowall NW (1992) Fabry disease: immunocytochemical characterization of neuronal involvement. Annals Neurology: Official J Am Neurol Association Child Neurol Soc 31:409\u2013415","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"key":"2925_CR20","doi-asserted-by":"crossref","unstructured":"Deane JE, Graham SC, Kim NN, Stein PE, Mcnair R, Cach\u00f3n-Gonz\u00e1lez MB, Cox TM, Read RJ (2011) Insights into Krabbe disease from structures of galactocerebrosidase. Proceedings of the National Academy of Sciences, 108, 15169\u201315173","DOI":"10.1073\/pnas.1105639108"},{"key":"2925_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10545-012-9560-4","volume":"36","author":"R Debs","year":"2013","unstructured":"Debs R, Froissart R, Aubourg P, Papeix C, Douillard C, Degos B, Fontaine B, Audoin B, Lacour A, Said G (2013) Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metabolic Disease: Official J Soc Study Inborn Errors Metabolism 36:859\u2013868","journal-title":"J Inherit Metabolic Disease: Official J Soc Study Inborn Errors Metabolism"},{"key":"2925_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/jnen\/nlz139","volume":"79","author":"K Del Tredici","year":"2020","unstructured":"Del Tredici K, Ludolph AC, Feldengut S, Jacob C, Reichmann H, Bohl JR, Braak H (2020) Fabry disease with concomitant lewy body disease. J Neuropathology Experimental Neurol 79:378\u2013392","journal-title":"J Neuropathology Experimental Neurol"},{"key":"2925_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2011.05.007","volume":"45","author":"PK Duffner","year":"2011","unstructured":"Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL (2011) Early infantile Krabbe disease: results of the world-wide Krabbe registry. Pediatr Neurol 45:141\u2013148","journal-title":"Pediatr Neurol"},{"key":"2925_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2012.02.023","volume":"46","author":"PK Duffner","year":"2012","unstructured":"Duffner PK, Barczykowski A, Kay DM, Jalal K, Yan L, Abdelhalim A, Gill S, Gill AL, Carter R (2012) Later onset phenotypes of Krabbe disease: results of the world-wide registry. Pediatr Neurol 46:298\u2013306","journal-title":"Pediatr Neurol"},{"key":"2925_CR25","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/ijms19123726","volume":"19","author":"G Duro","year":"2018","unstructured":"Duro G, Zizzo C, Cammarata G, Burlina A, Burlina A, Polo G, Scalia S, Oliveri R, Sciarrino S, Francofonte D (2018) Mutations in the Gla gene and LysoGb3: is it really Anderson-Fabry disease? Int J Mol Sci 19:3726","journal-title":"Int J Mol Sci"},{"key":"2925_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-021-02266-7","volume":"141","author":"D Erskine","year":"2021","unstructured":"Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, Mckeith I (2021) Lipids, lysosomes and mitochondria: insights into lewy body formation from rare Monogenic disorders. Acta Neuropathol 141:511\u2013526","journal-title":"Acta Neuropathol"},{"key":"2925_CR27","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/sj.emboj.7600211","volume":"23","author":"CO Fernandez","year":"2004","unstructured":"Fernandez CO, Hoyer W, Zweckstetter M, Jares-Erijman EA, Subramaniam V, Griesinger C, Jovin TM (2004) Nmr of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J 23:2039\u20132046","journal-title":"EMBO J"},{"key":"2925_CR28","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1073\/pnas.1604645113","volume":"113","author":"P Flagmeier","year":"2016","unstructured":"Flagmeier P, Meisl G, Vendruscolo M, Knowles TP, Dobson CM, Buell AK, Galvagnion C (2016) Mutations associated with Familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation. Proc Natl Acad Sci 113:10328\u201310333","journal-title":"Proc Natl Acad Sci"},{"key":"2925_CR29","doi-asserted-by":"crossref","unstructured":"Flores-Le\u00f3n M, Outeiro TF (2025) Expanding our Understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy. The Febs Journal","DOI":"10.1111\/febs.70011"},{"key":"2925_CR30","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1038\/s41467-022-34552-7","volume":"13","author":"B Frieg","year":"2022","unstructured":"Frieg B, Antonschmidt L, Dienemann C, Geraets JA, Najbauer EE, Matthes D, De Groot BL, Andreas LB, Becker S, Griesinger C (2022) The 3D structure of lipidic fibrils of \u03b1-synuclein. Nat Commun 13:6810","journal-title":"Nat Commun"},{"key":"2925_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/08830738211027717","volume":"37","author":"G Ghabash","year":"2022","unstructured":"Ghabash G, Wilkes J, Barney BJ, Bonkowsky JL (2022) Hospitalization burden and incidence of Krabbe disease. J Child Neurol 37:12\u201319","journal-title":"J Child Neurol"},{"issue":"09","key":"2925_CR32","first-page":"607301","volume":"202408","author":"S Ghanem","year":"2024","unstructured":"Ghanem S, Hawksworth J, Thom S, E Hartanto A, O\u2019Neill J, Ponraj J, Mansour S, Attems J, Pyle A, Johnson L (2024) Seed-competent \u03b1-synuclein pathology in metachromatic leukodystrophy: the expanding spectrum of \u03b1-synucleinopathy in sphingolipidoses. BioRxiv 202408(09):607301","journal-title":"BioRxiv"},{"key":"2925_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1651-2227.2008.00648.x","volume":"97","author":"V Gieselmann","year":"2008","unstructured":"Gieselmann V (2008) Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. Acta Paediatr 97:15\u201321","journal-title":"Acta Paediatr"},{"key":"2925_CR34","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1212\/WNL.53.6.1284","volume":"53","author":"E Gomez-Tortosa","year":"1999","unstructured":"Gomez-Tortosa E, Newell K, Irizarry M, Albert M, Growdon J, Hyman BT (1999) Clinical and quantitative pathologic correlates of dementia with lewy bodies. Neurology 53:1284\u20131284","journal-title":"Neurology"},{"key":"2925_CR35","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1074\/jbc.M109.060145","volume":"285","author":"AI Guce","year":"2010","unstructured":"Guce AI, Clark NE, Salgado EN, Ivanen DR, Kulminskaya AA, Brumer H, Garman SC (2010) Catalytic mechanism of human \u03b1-Galactosidase 2. J Biol Chem 285:3625\u20133632","journal-title":"J Biol Chem"},{"key":"2925_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19:175\u2013191","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2925_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/brain\/awac002","volume":"145","author":"C Hatton","year":"2022","unstructured":"Hatton C, Ghanem SS, Koss DJ, Abdi IY, Gibbons E, Guerreiro R, Bras J, Walker L, Gelpi E (2022) Prion-like \u03b1-synuclein pathology in the brain of infants with Krabbe disease. Brain 145:1257\u20131263","journal-title":"Brain"},{"key":"2925_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/089198870201500402","volume":"15","author":"JL Heidebrink","year":"2002","unstructured":"Heidebrink JL (2002) Is dementia with lewy bodies the second most common cause of dementia? J Geriatr Psychiatr Neurol 15:182\u2013187","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"2925_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajmg.1362","volume":"101","author":"S Holve","year":"2001","unstructured":"Holve S, Hu D, Mccandless SE (2001) Metachromatic leukodystrophy in the Navajo: fallout of the American-Indian wars of the nineteenth century. Am J Med Genet 101:203\u2013208","journal-title":"Am J Med Genet"},{"key":"2925_CR40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J","volume":"12","author":"M Horowitz","year":"1998","unstructured":"Horowitz M, Pasmanik-Chor M, Borochowitz Z, Falik\u2010Zaccai T, Heldmann K, Carmi R, Parvari R, Beit\u2010Or H, Goldman B, Peleg L (1998) Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Hum Mutat 12:240\u2013244","journal-title":"Hum Mutat"},{"key":"2925_CR41","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/hmg\/6.11.1879","volume":"6","author":"J-Q Huang","year":"1997","unstructured":"Huang J-Q, Trasler JM, Igdoura S, Michaud J, Hanai N, Gravel RA (1997) Apoptotic cell death in mouse models of Gm2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 6:1879\u20131885","journal-title":"Hum Mol Genet"},{"key":"2925_CR42","unstructured":"Hughes DA, Pastores GM (2023) Gaucher disease. GeneReviews\u00ae[Internet]"},{"key":"2925_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/diagnostics14020208","volume":"14","author":"A Iorio","year":"2024","unstructured":"Iorio A, Luca F, Pozzi A, Rao CM, Chimenti C, Di Fusco SA, Rossini R, Caretta G, Cornara S, Giubilato S (2024) Anderson\u2013Fabry disease: red flags for early diagnosis of cardiac involvement. Diagnostics 14:208","journal-title":"Diagnostics"},{"key":"2925_CR44","unstructured":"Jain M, De Jesus O (2020) Krabbe disease"},{"key":"2925_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA, Lantos PL (2010) Papp\u2013Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol 119:657\u2013667","journal-title":"Acta Neuropathol"},{"key":"2925_CR46","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1007\/PL00014401","volume":"159","author":"MM Kaback","year":"2000","unstructured":"Kaback MM (2000) Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatrics 159:S192\u2013S195","journal-title":"Eur J Pediatrics"},{"key":"2925_CR47","doi-asserted-by":"publisher","first-page":"105920","DOI":"10.1016\/j.parkreldis.2023.105920","volume":"117","author":"S Kaplan","year":"2023","unstructured":"Kaplan S, Xie H, Wang J (2023) Estimating the prevalence and incidence of multiple system atrophy in the USA: insights from a National claims database. Parkinsonism Relat Disord 117:105920","journal-title":"Parkinsonism Relat Disord"},{"key":"2925_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.410200208","volume":"20","author":"EM Kaye","year":"1986","unstructured":"Kaye EM, Ullman MD, Wilson ER, Barranger JA (1986) Type 2 and type 3 gaucher disease: a morphological and biochemical study. Annals Neurology: Official J Am Neurol Association Child Neurol Soc 20:223\u2013230","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"key":"2925_CR50","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/hmg\/ddy105","volume":"27","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Jeon S, Burbulla LF, Krainc D (2018b) Acid ceramidase Inhibition ameliorates \u03b1-synuclein accumulation upon loss of GBA1 function. Hum Mol Genet 27:1972\u20131988","journal-title":"Hum Mol Genet"},{"key":"2925_CR49","doi-asserted-by":"crossref","unstructured":"Kim D, Hwang H, Choi S, Kwon SH, Lee S, Park JH, Kim S, Ko HS 2018a. D409H GBA1 mutation accelerates the progression of pathology in A53T \u03b1-synuclein Transgenic mouse model. Acta Neuropathol Commun, 6, 1\u201312","DOI":"10.1186\/s40478-018-0538-9"},{"key":"2925_CR51","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1038\/cdd.2017.128","volume":"24","author":"J Knupp","year":"2017","unstructured":"Knupp J, Martinez-Montanes F, Van Den Bergh F, Cottier S, Schneiter R, Beard D, Chang A (2017) Sphingolipid accumulation causes mitochondrial dysregulation and cell death. Cell Death Differ 24:2044\u20132053","journal-title":"Cell Death Differ"},{"key":"2925_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW (2021) Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegeneration 16:83","journal-title":"Mol Neurodegeneration"},{"key":"2925_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","volume":"33","author":"I Kraoua","year":"2011","unstructured":"Kraoua I, Sedel F, Caillaud C, Froissart R, Stirnemann J, Chaurand G, Flodrops H, Tari S, Gourfinkel-An I, Mathieu S (2011) A French experience of type 3 gaucher disease: phenotypic diversity and neurological outcome of 10 patients. Brain Develop 33:131\u2013139","journal-title":"Brain Develop"},{"key":"2925_CR54","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/ijms21176213","volume":"21","author":"AF Leal","year":"2020","unstructured":"Leal AF, Benincore-Fl\u00f3rez E, Solano-Galarza D, Garz\u00f3n Jaramillo RG, Echeverri-Pe\u00f1a OY, Suarez DA, Alm\u00e9ciga-D\u00edaz CJ, Espejo-Mojica AJ (2020) GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int J Mol Sci 21:6213","journal-title":"Int J Mol Sci"},{"key":"2925_CR56","doi-asserted-by":"crossref","unstructured":"Lee RE (1968) The fine structure of the cerebroside occurring in Gaucher\u2019s disease. Proceedings of the National Academy of Sciences, 61, 484\u2013489","DOI":"10.1073\/pnas.61.2.484"},{"key":"2925_CR55","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/brain\/awz205","volume":"142","author":"JS Lee","year":"2019","unstructured":"Lee JS, Kanai K, Suzuki M, Kim WS, Yoo HS, Fu Y, Kim DK, Jung BC, Choi M, Oh KW, Li Y, Nakatani M, Nakazato T, Sekimoto S, Funayama M, Yoshino H, Kubo SI, Nishioka K, Sakai R, Ueyama M, Mochizuki H, Lee HJ, Sardi SP, Halliday GM, Nagai Y, Lee PH, Hattori N, Lee SJ (2019) Arylsulfatase A, a genetic modifier of Parkinson\u2019s disease, is an alpha-synuclein chaperone. Brain 142:2845\u20132859","journal-title":"Brain"},{"key":"2925_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fnagi.2018.00402","volume":"10","author":"G Li","year":"2018","unstructured":"Li G, Cui S, Du J, Liu J, Zhang P, Fu Y, He Y, Zhou H, Ma J, Chen S (2018) Association of GALC, ZNF184, IL1R2 and ELOVL7 with Parkinson\u2019s disease in Southern Chinese. Front Aging Neurosci 10:402","journal-title":"Front Aging Neurosci"},{"key":"2925_CR58","doi-asserted-by":"publisher","first-page":"20097","DOI":"10.1073\/pnas.1912108116","volume":"116","author":"Y Li","year":"2019","unstructured":"Li Y, Xu Y, Benitez BA, Nagree MS, Dearborn JT, Jiang X, Guzman MA, Woloszynek JC, Giaramita A, Yip BK (2019) Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proc Natl Acad Sci 116:20097\u201320103","journal-title":"Proc Natl Acad Sci"},{"key":"2925_CR59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","volume":"30","author":"G Lin","year":"2019","unstructured":"Lin G, Wang L, Marcogliese PC, Bellen HJ (2019) Sphingolipids in the pathogenesis of Parkinson\u2019s disease and parkinsonism. Trends Endocrinol Metabolism 30:106\u2013117","journal-title":"Trends Endocrinol Metabolism"},{"key":"2925_CR60","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM (2007) Cardiac manifestations of Anderson\u2013Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28:1228\u20131235","journal-title":"Eur Heart J"},{"key":"2925_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.26542","volume":"93","author":"WRW Martin","year":"2023","unstructured":"Martin WRW, Younce JR, Campbell MC, Racette BA, Norris SA, Ushe M, Criswell S, Davis AA, Alfradique-Dunham I, Maiti B, Cairns NJ, Perrin RJ, Kotzbauer PT, Perlmutter JS (2023) Neocortical lewy body pathology parallels Parkinson\u2019s dementia, but not always. Ann Neurol 93:184\u2013195","journal-title":"Ann Neurol"},{"key":"2925_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu Y-H, Sun Y, Knight AL, Mclean PJ, Caldwell GA, Sidransky E, Grabowski GA, Krainc D (2011) Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37\u201352","journal-title":"Cell"},{"key":"2925_CR63","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","volume":"36","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli JR, Zunke F, Tsunemi T, Toker NJ, Jeon S, Burbulla LF, Patnaik S, Sidransky E, Marugan JJ, Sue CM (2016) Activation of \u03b2-glucocerebrosidase reduces pathological \u03b1-synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons. J Neurosci 36:7693\u20137706","journal-title":"J Neurosci"},{"key":"2925_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG Mckeith","year":"2017","unstructured":"Mckeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG (2017) Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"2925_CR65","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249\u2013254","journal-title":"JAMA"},{"key":"2925_CR66","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/brain\/awx221","volume":"140","author":"A Migdalska-Richards","year":"2017","unstructured":"Migdalska-Richards A, Wegrzynowicz M, Rusconi R, Deangeli G, Di Monte DA, Spillantini MG, Schapira AH (2017) The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice. Brain 140:2706\u20132721","journal-title":"Brain"},{"key":"2925_CR67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.braindev.2005.04.005","volume":"28","author":"C Mignot","year":"2006","unstructured":"Mignot C, Doummar D, Maire I, De Villemeur TB, Group FTGDS (2006) Type 2 gaucher disease: 15 new cases and review of the literature. Brain Develop 28:39\u201348","journal-title":"Brain Develop"},{"key":"2925_CR68","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/B978-0-444-59565-2.00040-X","volume":"113","author":"C Mignot","year":"2013","unstructured":"Mignot C, Gelot A, De Villemeur TB (2013) Gaucher disease. Handb Clin Neurol 113:1709\u20131715","journal-title":"Handb Clin Neurol"},{"key":"2925_CR69","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1073\/pnas.1400768111","volume":"111","author":"PK Mistry","year":"2014","unstructured":"Mistry PK, Liu J, Sun L, Chuang W-L, Yuen T, Yang R, Lu P, Zhang K, Li J, Keutzer J (2014) Glucocerebrosidase 2 gene deletion rescues type 1 gaucher disease. Proc Natl Acad Sci 111:4934\u20134939","journal-title":"Proc Natl Acad Sci"},{"key":"2925_CR70","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S, Bjornevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schule B, Park DS, Riise T, Scherzer CR (2017) beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson\u2019s disease. Science 357:891\u2013898","journal-title":"Science"},{"key":"2925_CR71","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ajh.24491","volume":"91","author":"V Murugesan","year":"2016","unstructured":"Murugesan V, Chuang WL, Liu J, Lischuk A, Kacena K, Lin H, Pastores GM, Yang R, Keutzer J, Zhang K (2016) Glucosylsphingosine is a key biomarker of gaucher disease. Am J Hematol 91:1082\u20131089","journal-title":"Am J Hematol"},{"key":"2925_CR72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","volume":"22","author":"L Nalysnyk","year":"2017","unstructured":"Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N (2017) Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology 22:65\u201373","journal-title":"Hematology"},{"key":"2925_CR73","doi-asserted-by":"crossref","unstructured":"Navarro C, Teijeira S, Ortolano S, Fernandez JM, Millan BS, Fachal C, Allegue F, Barrera S (2010) Histopathology of skin in Fabry Disease. Fabry Disease, 275\u2013292","DOI":"10.1007\/978-90-481-9033-1_15"},{"key":"2925_CR74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.nbd.2017.11.006","volume":"110","author":"MP Nelson","year":"2018","unstructured":"Nelson MP, Boutin M, Tonia ET, Lu H, Haley ED, Ouyang X, Zhang J, Auray-Blais C, Shacka JJ (2018) The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson\u2019s disease brain in association with the pathologic accumulation of alpha-synuclein. Neurobiol Dis 110:68\u201381","journal-title":"Neurobiol Dis"},{"key":"2925_CR75","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1440-1789.2008.00883.x","volume":"28","author":"R Okeda","year":"2008","unstructured":"Okeda R, Nisihara M (2008) An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia. Neuropathology 28:532\u2013540","journal-title":"Neuropathology"},{"key":"2925_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, Mckeith I (2019) Dementia with lewy bodies: an update and outlook. Mol Neurodegener 14:5","journal-title":"Mol Neurodegener"},{"key":"2925_CR77","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/mds.29314","volume":"38","author":"SC Parlar","year":"2023","unstructured":"Parlar SC, Grenn FP, Kim JJ, Baluwendraat C, Gan-Or Z (2023) Classification of GBA1 variants in Parkinson\u2019s disease: the GBA1\u2010PD browser. Mov Disord 38:489\u2013495","journal-title":"Mov Disord"},{"key":"2925_CR78","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, Elliott PM, Hagege A, Kuusisto J, Linhart A (2021) Cardiac involvement in Fabry disease: JACC review topic of the week. J Am Coll Cardiol 77:922\u2013936","journal-title":"J Am Coll Cardiol"},{"key":"2925_CR79","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","volume":"45","author":"M Pieroni","year":"2024","unstructured":"Pieroni M, Namdar M, Olivotto I, Desnick RJ (2024) Anderson\u2013Fabry disease management: role of the cardiologist. Eur Heart J 45:1395\u20131409","journal-title":"Eur Heart J"},{"key":"2925_CR80","doi-asserted-by":"publisher","first-page":"e0252325","DOI":"10.1371\/journal.pone.0252325","volume":"16","author":"NK Polinski","year":"2021","unstructured":"Polinski NK, Martinez TN, Gorodinsky A, Gareus R, Sasner M, Herberth M, Switzer R, Ahmad SO, Cosden M, Kandebo M (2021) Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model. PLoS ONE 16:e0252325","journal-title":"PLoS ONE"},{"key":"2925_CR81","doi-asserted-by":"publisher","first-page":"dmm049192","DOI":"10.1242\/dmm.049192","volume":"15","author":"NK Polinski","year":"2022","unstructured":"Polinski NK, Martinez TN, Ramboz S, Sasner M, Herberth M, Switzer R, Ahmad SO, Pelligrino LJ, Clark SW, Marcus JN (2022) The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models. Dis Models Mech 15:dmm049192","journal-title":"Dis Models Mech"},{"key":"2925_CR82","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 29:1583\u20131590","journal-title":"Mov Disord"},{"key":"2925_CR83","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/glycob\/cwab046","volume":"31","author":"S Reza","year":"2021","unstructured":"Reza S, Ugorski M, Sucha\u0144ski J (2021) Glucosylceramide and Galactosylceramide, small glycosphingolipids with significant impact on health and disease. Glycobiology 31:1416\u20131434","journal-title":"Glycobiology"},{"key":"2925_CR84","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.1073\/pnas.1108197108","volume":"108","author":"SP Sardi","year":"2011","unstructured":"Sardi SP, Clarke J, Kinnecom C, Tamsett TJ, Li L, Stanek LM, Passini MA, Grabowski GA, Schlossmacher MG, Sidman RL (2011) CNS expression of glucocerebrosidase corrects \u03b1-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc Natl Acad Sci 108:12101\u201312106","journal-title":"Proc Natl Acad Sci"},{"key":"2925_CR85","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1212\/WNL.49.5.1392","volume":"49","author":"J-I Satoh","year":"1997","unstructured":"Satoh J-I, Tokumoto H, Kurohara K, Yukitake M, Matsui M, Kuroda Y, Yamamoto T, Furuya H, Shinnoh N, Kobayashi T (1997) Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene. Neurology 49:1392\u20131399","journal-title":"Neurology"},{"key":"2925_CR86","unstructured":"Schiffmann R, Moore DF (2006) Neurological manifestations of Fabry disease. Fabry disease: perspectives from 5 years of Fos"},{"key":"2925_CR87","doi-asserted-by":"crossref","unstructured":"Senkevich K, Beletskaia M, Dworkind A, Yu E, Ahmad J, Ruskey JA, Asayesh F, Spiegelman D, Fahn S, Waters C, Monchi O, Dauvilliers Y, Dupre N, Greenbaum L, Hassin-Baer S, Nagornov I, Tyurin A, Miliukhina I, Timofeeva A, Emelyanov A, Trempe JF, Zakharova E, Alcalay RN, Pchelina S (2023a) & Gan-Or, Z. Association of Rare Variants in ARSA with Parkinson\u2019s Disease. Mov Disord","DOI":"10.1002\/mds.29521"},{"key":"2925_CR88","doi-asserted-by":"crossref","unstructured":"Senkevich K, Zorca CE, Dworkind A, Rudakou U, Somerville E, Yu E, Ermolaev A, Nikanorova D, Ahmad J, Ruskey JA 2023b. GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson\u2019s disease. Brain, 146, 1859\u20131872","DOI":"10.1093\/brain\/awac413"},{"key":"2925_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1252-3","volume":"19","author":"C Silveira","year":"2019","unstructured":"Silveira C, Mackinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow S, Wells J, Borrie M, Tirona R (2019) Ambroxol as a novel disease-modifying treatment for Parkinson\u2019s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol 19:1\u201310","journal-title":"BMC Neurol"},{"key":"2925_CR90","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/path.4328","volume":"232","author":"BR Smith","year":"2014","unstructured":"Smith BR, Santos MB, Marshall MS, Cantuti-Castelvetri L, Lopez\u2010Rosas A, Li G, Van Breemen R, Claycomb KI, Gallea JI, Celej MS (2014) Neuronal inclusions of \u03b1\u2010synuclein contribute to the pathogenesis of Krabbe disease. J Pathol 232:509\u2013521","journal-title":"J Pathol"},{"key":"2925_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00692212","volume":"49","author":"D Soffer","year":"1980","unstructured":"Soffer D, Yamanaka T, Wenger DA, Suzuki K, Suzuki K (1980) Central nervous system involvement in adult-onset Gaucher\u2019s disease. Acta Neuropathol 49:1\u20136","journal-title":"Acta Neuropathol"},{"key":"2925_CR92","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1021\/cr0100446","volume":"106","author":"S Sonnino","year":"2006","unstructured":"Sonnino S, Prinetti A, Mauri L, Chigorno V, Tettamanti G (2006) Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem Rev 106:2111\u20132125","journal-title":"Chem Rev"},{"key":"2925_CR93","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s12311-022-01453-w","volume":"22","author":"I Stankovic","year":"2023","unstructured":"Stankovic I, Fanciulli A, Sidoroff V, Wenning GK (2023) A review on the clinical diagnosis of multiple system atrophy. Cerebellum 22:825\u2013839","journal-title":"Cerebellum"},{"key":"2925_CR94","doi-asserted-by":"crossref","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, De Villemeur B, T., Berger MG (2017) A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci, 18","DOI":"10.3390\/ijms18020441"},{"key":"2925_CR95","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-007-0264-z","volume":"114","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Iseki E, Togo T, Yamaguchi A, Katsuse O, Katsuyama K, Kanzaki S, Shiozaki K, Kawanishi C, Yamashita S (2007) Neuronal and glial accumulation of \u03b1-and \u03b2-synucleins in human lipidoses. Acta Neuropathol 114:481\u2013489","journal-title":"Acta Neuropathol"},{"key":"2925_CR96","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.expneurol.2016.07.011","volume":"284","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Yamaguchi A, Yamanaka S, Kanzaki S, Kawashima M, Togo T, Katsuse O, Koumitsu N, Aoki N, Iseki E (2016) Accumulated \u03b1-synuclein affects the progression of GM2 gangliosidoses. Exp Neurol 284:38\u201349","journal-title":"Exp Neurol"},{"key":"2925_CR97","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","volume":"37","author":"YV Taguchi","year":"2017","unstructured":"Taguchi YV, Liu J, Ruan J, Pacheco J, Zhang X, Abbasi J, Keutzer J, Mistry PK, Chandra SS (2017) Glucosylsphingosine promotes \u03b1-synuclein pathology in mutant GBA-associated Parkinson\u2019s disease. J Neurosci 37:9617\u20139631","journal-title":"J Neurosci"},{"key":"2925_CR98","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B, Orvisky E, Lamarca M, Wong K, Rosenbaum H, Schiffmann R, Bembi B, Sidransky E (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104\u2013109","journal-title":"Mol Genet Metab"},{"key":"2925_CR99","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/j.1471-4159.1990.tb04942.x","volume":"55","author":"KI Toda","year":"1990","unstructured":"Toda KI, Kobayashi T, Goto I, Ohno K, Eto Y, Inui K, Okada S (1990) Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy. J Neurochem 55:1585\u20131591","journal-title":"J Neurochem"},{"key":"2925_CR100","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","volume":"51","author":"C T\u00f8ndel","year":"2008","unstructured":"T\u00f8ndel C, Bostad L, Hirth A, Svarstad E (2008) Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis 51:767\u2013776","journal-title":"Am J Kidney Dis"},{"key":"2925_CR101","unstructured":"Toro C, Shirvan L, Tifft C (2020) Hexa disorders."},{"key":"2925_CR102","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/EBC20190090","volume":"64","author":"M Van Eijk","year":"2020","unstructured":"Van Eijk M, Ferraz MJ, Boot RG, Aerts JM (2020) Lyso-glycosphingolipids: presence and consequences. Essays Biochem 64:565\u2013578","journal-title":"Essays Biochem"},{"key":"2925_CR103","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.beem.2014.10.001","volume":"29","author":"DF Van Rappard","year":"2015","unstructured":"Van Rappard DF, Boelens JJ, Wolf NI (2015) Metachromatic leukodystrophy: disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab 29:261\u2013273","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2925_CR104","first-page":"27","volume":"14","author":"AH Wise","year":"2018","unstructured":"Wise AH, Yang A, Naik H, Stauffer C, Zeid N, Liong C, Balwani M, Desnick RJ, Alcalay RN (2018) Parkinson\u2019s disease prevalence in Fabry disease: a survey study. Mol Genet Metabolism Rep 14:27\u201330","journal-title":"Mol Genet Metabolism Rep"},{"key":"2925_CR105","doi-asserted-by":"crossref","unstructured":"Wiseman JA, Halliday GM, Dieriks BV (2025) Neuronal \u03b1-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy. Brain, awaf030","DOI":"10.1093\/brain\/awaf030"},{"key":"2925_CR106","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK, Morrison A, Lwin A, Colegial C, Allman JM, Schiffmann R (2004) Neuropathology provides clues to the pathophysiology of gaucher disease. Mol Genet Metab 82:192\u2013207","journal-title":"Mol Genet Metab"},{"key":"2925_CR107","unstructured":"Xiao C, Tifft C, Toro C (2022) Sandhoff disease."},{"key":"2925_CR108","doi-asserted-by":"publisher","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","volume":"286","author":"TL Yap","year":"2011","unstructured":"Yap TL, Gruschus JM, Velayati A, Westbroek W, Goldin E, Moaven N, Sidransky E, Lee JC (2011) \u03b1-Synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and gaucher diseases. J Biol Chem 286:28080\u201328088","journal-title":"J Biol Chem"},{"key":"2925_CR109","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1074\/jbc.M114.610584","volume":"290","author":"TL Yap","year":"2015","unstructured":"Yap TL, Jiang Z, Heinrich F, Gruschus JM, Pfefferkorn CM, Barros M, Curtis JE, Sidransky E, Lee JC (2015) Structural features of membrane-bound glucocerebrosidase and \u03b1-synuclein probed by neutron reflectometry and fluorescence spectroscopy. J Biol Chem 290:744\u2013754","journal-title":"J Biol Chem"},{"key":"2925_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","volume":"13","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kim D, Kim S, Kim S, Karuppagounder SS, Kwon S-H, Lee S, Kam T-I, Lee S, Ham S (2018) \u03b1-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol Neurodegeneration 13:1\u201319","journal-title":"Mol Neurodegeneration"},{"key":"2925_CR111","first-page":"663","volume":"32","author":"J Zlotogora","year":"1980","unstructured":"Zlotogora J, Bach G, Barak Y, Elian E (1980) Metachromatic leukodystrophy in the habbanite Jews: high frequency in a genetic isolate and screening for heterozygotes. Am J Hum Genet 32:663","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02925-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:05:28Z","timestamp":1779887128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02925-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":111,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2925"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02925-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human brain tissue for Fig.\u00a0\n                      \n                      was supplied by Newcastle Brain Tissue Resource, a UK Human Tissue Authority-approved tissue repository with ethical approval to store\n                      post-mortem\n                      brain tissue with appropriate legal consent (Newcastle and North Tyneside Health Authority research ethics committee reference: 19\/NE\/0008). Consent for tissue donation was made by donors or next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}